$EPR
EPR Properties

2023 Q2 Form 10-Q Financial Statement

#000104545023000039 Filed on April 27, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $172.9M $171.4M $157.5M
YoY Change 7.77% 8.84% 40.9%
Cost Of Revenue $7.409M $7.555M $7.970M
YoY Change -0.63% -5.21% -19.49%
Gross Profit $165.5M $163.8M $149.5M
YoY Change 8.18% 9.59% 46.71%
Gross Profit Margin 95.72% 95.59% 94.94%
Selling, General & Admin $21.85M $20.84M $21.44M
YoY Change 9.39% -2.82% 23.93%
% of Gross Profit 13.2% 12.72% 14.34%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $43.71M $40.00M $38.80M
YoY Change 7.21% 3.09% -0.26%
% of Gross Profit 26.41% 24.41% 25.95%
Operating Expenses $74.71M $70.99M $69.58M
YoY Change 7.33% 2.02% 15.01%
Operating Profit $90.79M $91.71M $79.92M
YoY Change 22.9% 14.74% 93.05%
Interest Expense -$32.21M $31.72M $33.26M
YoY Change -196.75% -4.62% -15.14%
% of Operating Profit -35.48% 34.59% 41.62%
Other Income/Expense, Net $9.161M $8.950M $8.097M
YoY Change 3.26% 10.53% 217.28%
Pretax Income $13.95M $58.00M $42.51M
YoY Change -66.27% 36.43% 1022.52%
Income Tax $347.0K $341.0K $318.0K
% Of Pretax Income 2.49% 0.59% 0.75%
Net Earnings $7.560M $57.66M $42.19M
YoY Change -81.52% 36.65% 1148.28%
Net Earnings / Revenue 4.37% 33.64% 26.79%
Basic Earnings Per Share $0.10 $0.69 $0.48
Diluted Earnings Per Share $0.10 $0.69 $0.48
COMMON SHARES
Basic Shares Outstanding 75.28M shares 75.29M shares 74.84M shares
Diluted Shares Outstanding 75.72M shares 75.28M shares 75.05M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $99.71M $96.44M $323.8M
YoY Change -40.74% -70.21% -39.83%
Cash & Equivalents $99.71M $96.44M $323.8M
Short-Term Investments
Other Short-Term Assets $33.63M $38.79M $30.60M
YoY Change 13.25% 26.79% 12.48%
Inventory
Prepaid Expenses
Receivables $53.31M $50.59M $60.70M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $186.6M $185.8M $415.1M
YoY Change -27.7% -55.23% -37.38%
LONG-TERM ASSETS
Property, Plant & Equipment $4.953B $5.012B $4.947B
YoY Change -2.31% 1.31% -2.97%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $53.76M $50.98M $36.56M
YoY Change 12.7% 39.42% 29.2%
Other Assets $2.623M $2.599M $2.956M
YoY Change 105.4% -12.08% -49.9%
Total Long-Term Assets $5.517B $5.571B $5.403B
YoY Change -0.33% 3.11% -2.57%
TOTAL ASSETS
Total Short-Term Assets $186.6M $185.8M $415.1M
Total Long-Term Assets $5.517B $5.571B $5.403B
Total Assets $5.704B $5.757B $5.818B
YoY Change -1.55% -1.06% -6.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $74.49M $76.24M $93.00M
YoY Change 10.89% -18.02% -2.21%
Accrued Expenses $233.1M $238.1M $215.1M
YoY Change -3.1% 10.68% -1.05%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $335.9M $342.2M $335.1M
YoY Change 0.29% 2.12% 5.18%
LONG-TERM LIABILITIES
Long-Term Debt $2.813B $2.812B $2.806B
YoY Change 0.21% 0.21% -11.52%
Other Long-Term Liabilities $71.75M $71.60M $76.01M
YoY Change -1.49% -5.8% -9.08%
Total Long-Term Liabilities $2.885B $2.883B $2.882B
YoY Change 0.17% 0.05% -11.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $335.9M $342.2M $335.1M
Total Long-Term Liabilities $2.885B $2.883B $2.882B
Total Liabilities $3.221B $3.225B $3.217B
YoY Change 0.18% 0.26% -9.97%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $829.0K $829.0K $825.0K
YoY Change 0.48% 0.48% 0.49%
Preferred Stock
YoY Change
Treasury Stock (at cost) $274.0M $273.9M $269.6M
YoY Change 1.63% 1.59% 2.13%
Treasury Stock Shares 7.518M shares
Shareholders Equity $2.483B $2.531B $2.601B
YoY Change
Total Liabilities & Shareholders Equity $5.704B $5.757B $5.818B
YoY Change -1.55% -1.06% -6.28%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $7.560M $57.66M $42.19M
YoY Change -81.52% 36.65% 1148.28%
Depreciation, Depletion And Amortization $43.71M $40.00M $38.80M
YoY Change 7.21% 3.09% -0.26%
Cash From Operating Activities $99.36M $121.5M $128.1M
YoY Change 11.68% -5.12% 63.57%
INVESTING ACTIVITIES
Capital Expenditures $24.62M $61.38M -$25.93M
YoY Change -116.08% -336.71% -36.13%
Acquisitions
YoY Change
Other Investing Activities -$3.340M -$130.0K $896.0K
YoY Change -86.94% -114.51% -91.63%
Cash From Investing Activities -$27.96M -$61.51M -$25.04M
YoY Change -84.35% 145.7% -16.25%
FINANCING ACTIVITIES
Cash Dividend Paid $67.99M $62.15M
YoY Change 9.39% 930.01%
Common Stock Issuance & Retirement, Net $4.090M
YoY Change 55.16%
Debt Paid & Issued, Net $0.00
YoY Change -100.0%
Cash From Financing Activities -68.20M -$71.49M -$66.29M
YoY Change 0.45% 7.83% -87.55%
NET CHANGE
Cash From Operating Activities 99.36M $121.5M $128.1M
Cash From Investing Activities -27.96M -$61.51M -$25.04M
Cash From Financing Activities -68.20M -$71.49M -$66.29M
Net Change In Cash 3.196M -$11.47M $36.82M
YoY Change -102.03% -131.17% -107.61%
FREE CASH FLOW
Cash From Operating Activities $99.36M $121.5M $128.1M
Capital Expenditures $24.62M $61.38M -$25.93M
Free Cash Flow $74.74M $60.15M $154.0M
YoY Change -69.13% -60.95% 29.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001045450
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
75279238 shares
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-13561
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
EPR PROPERTIES
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
43-1790877
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
909 Walnut Street,
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 200
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Kansas City,
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MO
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
64106
CY2023Q1 dei City Area Code
CityAreaCode
(816)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
472-1700
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
75279238 shares
CY2023Q1 us-gaap Real Estate Owned Accumulated Depreciation
RealEstateOwnedAccumulatedDepreciation
1341527000 usd
CY2022Q4 us-gaap Real Estate Owned Accumulated Depreciation
RealEstateOwnedAccumulatedDepreciation
1302640000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
11400000 usd
CY2023Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
4708342000 usd
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
4714136000 usd
CY2023Q1 us-gaap Land Available For Development
LandAvailableForDevelopment
20168000 usd
CY2022Q4 us-gaap Land Available For Development
LandAvailableForDevelopment
20168000 usd
CY2023Q1 us-gaap Development In Process
DevelopmentInProcess
85829000 usd
CY2022Q4 us-gaap Development In Process
DevelopmentInProcess
76029000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
197357000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
200985000 usd
CY2023Q1 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
461263000 usd
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
457268000 usd
CY2023Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
50978000 usd
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
52964000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
96438000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
107934000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2599000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2577000 usd
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
50591000 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
53587000 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
83050000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
73053000 usd
CY2023Q1 us-gaap Assets
Assets
5756615000 usd
CY2022Q4 us-gaap Assets
Assets
5758701000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
76244000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
80087000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
238096000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
241407000 usd
CY2023Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
21826000 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
21405000 usd
CY2023Q1 epr Preferred Dividends Payable Current And Noncurrent
PreferredDividendsPayableCurrentAndNoncurrent
6033000 usd
CY2022Q4 epr Preferred Dividends Payable Current And Noncurrent
PreferredDividendsPayableCurrentAndNoncurrent
6033000 usd
CY2023Q1 us-gaap Deferred Revenue
DeferredRevenue
71601000 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
63939000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
2811653000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
2810111000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
3225453000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
3222982000 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
82905229 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
82545501 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
829000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
825000 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3910235000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3899732000 usd
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
7628551 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
7520227 shares
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
273904000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
269751000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1823000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1897000 usd
CY2023Q1 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
1107969000 usd
CY2022Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
1097132000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2531162000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2535719000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5756615000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5758701000 usd
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
151591000 usd
CY2022Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
139603000 usd
CY2023Q1 us-gaap Other Income
OtherIncome
9333000 usd
CY2022Q1 us-gaap Other Income
OtherIncome
9305000 usd
CY2023Q1 us-gaap Interest And Fee Income Loans Commercial And Residential Real Estate
InterestAndFeeIncomeLoansCommercialAndResidentialRealEstate
10472000 usd
CY2022Q1 us-gaap Interest And Fee Income Loans Commercial And Residential Real Estate
InterestAndFeeIncomeLoansCommercialAndResidentialRealEstate
8564000 usd
CY2023Q1 us-gaap Revenues
Revenues
171396000 usd
CY2022Q1 us-gaap Revenues
Revenues
157472000 usd
CY2023Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
14155000 usd
CY2022Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
13939000 usd
CY2023Q1 us-gaap Other Expenses
OtherExpenses
8950000 usd
CY2022Q1 us-gaap Other Expenses
OtherExpenses
8097000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13965000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13224000 usd
CY2023Q1 epr Transaction Costs
TransactionCosts
270000 usd
CY2022Q1 epr Transaction Costs
TransactionCosts
2247000 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
587000 usd
CY2022Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-306000 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
4351000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
41204000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
40044000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
79131000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
81596000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-560000 usd
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
91705000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
75876000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
31722000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
33260000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1985000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-106000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
57998000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
42510000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
341000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
318000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
57657000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
42192000 usd
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
6033000 usd
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
6033000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
51624000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
36159000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.69
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.48
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75084000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74843000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75283000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75047000 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
57657000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
42192000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
230000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2606000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-304000 usd
CY2022Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-2090000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
57583000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
42708000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2618039000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 usd
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
4416000 usd
CY2022Q1 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
4250000 usd
CY2022Q1 epr Employee Service Share Based Compensation Restricted Stock Units And Restricted Shares Unrecognized Compensation Cost On Nonvested Awards
EmployeeServiceShareBasedCompensationRestrictedStockUnitsAndRestrictedSharesUnrecognizedCompensationCostOnNonvestedAwards
4245000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2606000 usd
CY2022Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-2090000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
42192000 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
228000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.7750
CY2022Q1 us-gaap Dividends
Dividends
58099000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2601114000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2535719000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
5372000 usd
CY2023Q1 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
3565000 usd
CY2023Q1 epr Employee Service Share Based Compensation Restricted Stock Units And Restricted Shares Unrecognized Compensation Cost On Nonvested Awards
EmployeeServiceShareBasedCompensationRestrictedStockUnitsAndRestrictedSharesUnrecognizedCompensationCostOnNonvestedAwards
4322000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
230000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-304000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
57657000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
225000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.825
CY2023Q1 us-gaap Dividends
Dividends
62109000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2531162000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
57657000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
42192000 usd
CY2023Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 usd
CY2022Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
4351000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-560000 usd
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 usd
CY2023Q1 epr Gain On Insurance Recovery
GainOnInsuranceRecovery
0 usd
CY2022Q1 epr Gain On Insurance Recovery
GainOnInsuranceRecovery
552000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-90000 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1985000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-106000 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
587000 usd
CY2022Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-306000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
41204000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
40044000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2129000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2071000 usd
CY2023Q1 us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
-89000 usd
CY2022Q1 us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
-87000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4322000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4245000 usd
CY2023Q1 epr Increase Decreasein Operating Lease Assetsand Liabilities Net
IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet
317000 usd
CY2022Q1 epr Increase Decreasein Operating Lease Assetsand Liabilities Net
IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet
-49000 usd
CY2023Q1 epr Increase Decrease In Mortgage Notes Accrued Interest Receivable
IncreaseDecreaseInMortgageNotesAccruedInterestReceivable
296000 usd
CY2022Q1 epr Increase Decrease In Mortgage Notes Accrued Interest Receivable
IncreaseDecreaseInMortgageNotesAccruedInterestReceivable
-310000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2998000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-17424000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
6276000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5861000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8861000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
15132000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
7661000 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
9067000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
121530000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
128087000 usd
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
46669000 usd
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
20726000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
4029000 usd
CY2022Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
61000 usd
CY2023Q1 us-gaap Payments To Acquire Mortgage Notes Receivable
PaymentsToAcquireMortgageNotesReceivable
1427000 usd
CY2022Q1 us-gaap Payments To Acquire Mortgage Notes Receivable
PaymentsToAcquireMortgageNotesReceivable
0 usd
CY2023Q1 us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
132000 usd
CY2022Q1 us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
151000 usd
CY2023Q1 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
3025000 usd
CY2022Q1 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
0 usd
CY2023Q1 us-gaap Proceeds From Sale And Collection Of Notes Receivable
ProceedsFromSaleAndCollectionOfNotesReceivable
161000 usd
CY2022Q1 us-gaap Proceeds From Sale And Collection Of Notes Receivable
ProceedsFromSaleAndCollectionOfNotesReceivable
75000 usd
CY2023Q1 epr Proceeds From Insurance Recovery
ProceedsFromInsuranceRecovery
0 usd
CY2022Q1 epr Proceeds From Insurance Recovery
ProceedsFromInsuranceRecovery
609000 usd
CY2023Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
14711000 usd
CY2022Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
5205000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-61510000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25035000 usd
CY2023Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
74000 usd
CY2022Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
48000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
141000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
160000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3565000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4250000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
67988000 usd
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
62151000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-71486000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-66293000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-8000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-11474000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
36816000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110511000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
289901000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
99037000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
326717000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
107934000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
288822000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2577000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1079000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110511000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
289901000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
96438000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
323761000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2599000 usd
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2956000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
99037000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
326717000 usd
CY2023Q1 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
134000 usd
CY2022Q1 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
35255000 usd
CY2023Q1 us-gaap Transfer Of Other Real Estate
TransferOfOtherRealEstate
1321000 usd
CY2022Q1 us-gaap Transfer Of Other Real Estate
TransferOfOtherRealEstate
0 usd
CY2023Q1 epr Issuance Of Restricted Securities To Employees And Directors
IssuanceOfRestrictedSecuritiesToEmployeesAndDirectors
21698000 usd
CY2022Q1 epr Issuance Of Restricted Securities To Employees And Directors
IssuanceOfRestrictedSecuritiesToEmployeesAndDirectors
19791000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
17913000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
17298000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
253000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
783000 usd
CY2022Q1 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
200000 usd
CY2023Q1 epr Increase Decrease In Accrued Capital Expenditures
IncreaseDecreaseInAccruedCapitalExpenditures
-7510000 usd
CY2022Q1 epr Increase Decrease In Accrued Capital Expenditures
IncreaseDecreaseInAccruedCapitalExpenditures
5928000 usd
CY2023Q1 epr Number Of Master Leases
NumberOfMasterLeases
2 pure
CY2023Q1 epr Number Of Properties Subject To Potential Lease Rejection
NumberOfPropertiesSubjectToPotentialLeaseRejection
3 years
CY2023Q1 epr Straight Line Rent Receivable
StraightLineRentReceivable
47013000 usd
CY2022Q4 epr Straight Line Rent Receivable
StraightLineRentReceivable
44986000 usd
CY2023Q1 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
29600000 usd
CY2022Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
31100000 usd
CY2023Q1 us-gaap Straight Line Rent
StraightLineRent
2100000 usd
CY2022Q1 us-gaap Straight Line Rent
StraightLineRent
600000 usd
CY2023Q1 epr Straightlinerentwriteoff
Straightlinerentwriteoff
0 usd
CY2022Q1 epr Straightlinerentwriteoff
Straightlinerentwriteoff
0 usd
CY2023Q1 us-gaap Recovery Of Direct Costs
RecoveryOfDirectCosts
4700000 usd
CY2022Q1 us-gaap Recovery Of Direct Costs
RecoveryOfDirectCosts
4500000 usd
CY2023Q1 epr Operating Lease Percentage Revenue
OperatingLeasePercentageRevenue
1800000 usd
CY2022Q1 epr Operating Lease Percentage Revenue
OperatingLeasePercentageRevenue
3400000 usd
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
50591000 usd
CY2023Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
0 usd
CY2022Q1 us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
0 usd
CY2023Q1 us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
0 usd
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations of Risk</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regal, AMC and Topgolf USA (Topgolf) represented a significant portion of the Company's total revenue for the three months ended March 31, 2023 and 2022.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The following is a su</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mmary of the Company's total revenue derived from rental or interest payments from AMC, Topgolf and Regal (dollars in thousands): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"/><td style="width:10.029%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.158%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.158%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.514%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Total Revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">% of Company's Total Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Total Revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">% of Company's Total Revenue</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Regal</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,751 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,255 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMC</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,801 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,422 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Topgolf</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,672 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,383 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div>
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
53587000 usd
CY2023Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
6049869000 usd
CY2022Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
6016776000 usd
CY2023Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
1341527000 usd
CY2022Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
1302640000 usd
CY2023Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
4708342000 usd
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
4714136000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
40000000 usd
CY2022Q1 us-gaap Depreciation
Depreciation
38800000 usd
CY2023Q1 epr Notes Receivable
NotesReceivable
4400000 usd
CY2022Q4 epr Notes Receivable
NotesReceivable
2900000 usd
CY2023Q1 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
1500000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
0 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
21702000 usd
CY2023Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
587000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
7771000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
0 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
14518000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.825
CY2023Q1 us-gaap Long Term Debt Percentage Bearing Fixed Interest Rate
LongTermDebtPercentageBearingFixedInterestRate
0.0130
CY2023Q1 epr Long Term Debt Percentage Rate Sofr Floor
LongTermDebtPercentageRateSOFRFloor
0
CY2023Q1 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0611
CY2023Q1 epr Long Term Debt Percentage Rate Facility Fee
LongTermDebtPercentageRateFacilityFee
0.0025
CY2023Q1 us-gaap Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures
RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures
50978000 usd
CY2022Q4 us-gaap Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures
RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures
52964000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1985000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-106000 usd
CY2023Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
11200000 usd
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
47000 usd
CY2022Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-2220000 usd
CY2023Q1 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
351000 usd
CY2022Q1 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-130000 usd
CY2023Q1 us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
0 usd
CY2022Q1 us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
99000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
31722000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
33260000 usd
CY2023Q1 us-gaap Other Income
OtherIncome
9333000 usd
CY2022Q1 us-gaap Other Income
OtherIncome
9305000 usd
CY2023Q1 us-gaap Credit Risk Derivatives At Fair Value Net
CreditRiskDerivativesAtFairValueNet
50000000 usd
CY2023Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
0 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
0 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
57657000 usd
CY2023Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
6033000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
51624000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75084000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.69
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
51624000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75084000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
199000 shares
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
51624000 usd
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75283000 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
CY2022Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
42192000 usd
CY2022Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
6033000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
36159000 usd
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74843000 shares
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.48
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
36159000 usd
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74843000 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
204000 shares
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
36159000 usd
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75047000 shares
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
503912 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
50.38
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
352090 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
42.23
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
220437 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
54.40
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
13809 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
45.20
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
621756 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
44.45
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P1Y7M28D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
8300000 usd
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
10200000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
16600000 usd
CY2022Q4 us-gaap Number Of Properties Subject To Ground Leases
NumberOfPropertiesSubjectToGroundLeases
52
CY2023Q1 us-gaap Number Of Properties Subject To Ground Leases
NumberOfPropertiesSubjectToGroundLeases
52
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13965000 usd
CY2023Q1 epr Transaction Costs
TransactionCosts
270000 usd
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 integer
CY2023Q1 us-gaap Assets
Assets
5756615000 usd
CY2022Q4 us-gaap Assets
Assets
5758701000 usd
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
151591000 usd
CY2023Q1 us-gaap Other Income
OtherIncome
9333000 usd
CY2023Q1 us-gaap Interest And Fee Income Loans Commercial And Residential Real Estate
InterestAndFeeIncomeLoansCommercialAndResidentialRealEstate
10472000 usd
CY2023Q1 us-gaap Revenues
Revenues
171396000 usd
CY2023Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
14155000 usd
CY2023Q1 us-gaap Other Expenses
OtherExpenses
8950000 usd
CY2023Q1 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
23105000 usd
CY2023Q1 epr Net Operating Income Before Unallocated Items
NetOperatingIncomeBeforeUnallocatedItems
148291000 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
587000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
41204000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-560000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
31722000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1985000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
341000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
57657000 usd
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
6033000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
51624000 usd
CY2022Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
139603000 usd
CY2022Q1 us-gaap Other Income
OtherIncome
9305000 usd
CY2022Q1 us-gaap Interest And Fee Income Loans Commercial And Residential Real Estate
InterestAndFeeIncomeLoansCommercialAndResidentialRealEstate
8564000 usd
CY2022Q1 us-gaap Revenues
Revenues
157472000 usd
CY2022Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
13939000 usd
CY2022Q1 us-gaap Other Expenses
OtherExpenses
8097000 usd
CY2022Q1 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
22036000 usd
CY2022Q1 epr Net Operating Income Before Unallocated Items
NetOperatingIncomeBeforeUnallocatedItems
135436000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13224000 usd
CY2022Q1 epr Transaction Costs
TransactionCosts
2247000 usd
CY2022Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-306000 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
4351000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
40044000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
33260000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-106000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
318000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
42192000 usd
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
6033000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
36159000 usd
CY2023Q1 epr Number Of Mortgage Notes Receivable
NumberOfMortgageNotesReceivable
4 mortgagenotes
CY2023Q1 epr Mortgage Noteand Notes Receivable Commitments
MortgageNoteandNotesReceivableCommitments
84000000 usd
CY2023Q1 epr Numberof Surety Bonds
NumberofSuretyBonds
3
CY2023Q1 epr Suretybonds
Suretybonds
2700000 usd

Files In Submission

Name View Source Status
0001045450-23-000039-index-headers.html Edgar Link pending
0001045450-23-000039-index.html Edgar Link pending
0001045450-23-000039.txt Edgar Link pending
0001045450-23-000039-xbrl.zip Edgar Link pending
epr-20230331.htm Edgar Link pending
epr-20230331.xsd Edgar Link pending
epr-20230331_cal.xml Edgar Link unprocessable
epr-20230331_def.xml Edgar Link unprocessable
exhibit311331202310-q.htm Edgar Link pending
exhibit312331202310-q.htm Edgar Link pending
exhibit321331202310-q.htm Edgar Link pending
exhibit322331202310-q.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
epr-20230331_lab.xml Edgar Link unprocessable
epr-20230331_htm.xml Edgar Link completed
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
epr-20230331_pre.xml Edgar Link unprocessable